Spark Therapeutics, Inc. Common Stock
ONCE
ONCE was delisted on the 16th of December, 2019.
109 hedge funds and large institutions have $872M invested in Spark Therapeutics, Inc. Common Stock in 2015 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 45 increasing their positions, 25 reducing their positions, and 16 closing their positions.
88% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 16
80% more repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 25
15% more funds holding
Funds holding: 95 → 109 (+14)
4% less capital invested
Capital invested by funds: $908M → $872M (-$35.9M)
24% less call options, than puts
Call options by funds: $7.92M | Put options by funds: $10.5M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$82.3M |
| 2 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
+$31.4M |
| 3 |
State Street
Boston,
Massachusetts
|
+$27.6M |
| 4 |
Invesco
Atlanta,
Georgia
|
+$23M |
| 5 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$17.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$17.8M |
| 2 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$17.5M |
| 3 |
Allianz Asset Management
Munich,
Germany
|
-$14.4M |
| 4 |
Franklin Resources
San Mateo,
California
|
-$10.1M |
| 5 |
BA
BlackRock Advisors
Wilmington,
Delaware
|
-$8.26M |
ONCE Hedge Fund Activity: Q2 2015 in Review
109 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in Spark Therapeutics, Inc. Common Stock (ONCE) for Q2 2015, worth a combined $872M — down 4% from $908M a quarter earlier.
Buyers outnumbered sellers: 30 funds opened new ONCE positions and 16 closed out — a net gain of 14 holders — while 45 added to existing stakes and 25 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $82.3M. The largest seller was Janus Henderson Investors US, exiting entirely with an estimated $17.8M sold.
- 109 institutional investors held Spark Therapeutics, Inc. Common Stock (ONCE) as of Q2 2015, up from 95 in Q1 2015.
- Funds reported $872M of Spark Therapeutics, Inc. Common Stock stock for Q2 2015, down 4% quarter-over-quarter.
- 30 funds opened new Spark Therapeutics, Inc. Common Stock positions in Q2 2015 and 16 closed out, a net change of +14 holders.
- The largest Spark Therapeutics, Inc. Common Stock buyer in Q2 2015 was Fidelity Investments, an estimated $82.3M added.
- The largest Spark Therapeutics, Inc. Common Stock seller in Q2 2015 was Janus Henderson Investors US, an estimated $17.8M sold.
Based on aggregated 13F filings for Q2 2015.